SAMUEL R MD NUSSBAUM
CIK 1199310 · EVP & Chief Medical Officer · last filed 2021-06-16
SAMUEL R MD NUSSBAUM is an EVP & Chief Medical Officer who has filed 45 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for PROG, was dated Jun 16, 2021. Across all open-market trades the lifetime net is −$54.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $526.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$526.0K
6
45
-$54.57M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIORA THERAPEUTICS, INC. (PROG) Delisted | Director | 47,518 | $0.88 | $42.0K | $0 | 1 | 2021-06-16 |
| MOTS | Director | 77,464 | $0.00 | $8 | $50.0K | 7 | 2021-02-19 |
| CHRS | Director | — | $1.40 | — | $0 | 4 | 2021-01-13 |
| ANTX | EVP & Chief Medical Officer | 110,972 | $4.74 | $526.0K | -$1.65M | 1 | 2015-05-21 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Medical Officer | 110,972 | $482.58 | $53.55M | -$9.24M | 3 | 2015-05-13 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Chief Medical Officer | 143,757 | — | — | -$43.73M | 29 | 2014-11-04 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-16 | BIORA THERAPEUTICS, INC. (PROG) Delisted | Grant (A) | +29,183 | $0 | EDGAR |
| 2021-02-19 | MOTS | Grant (A) | +50,225 | $0 | EDGAR |
| 2021-01-14 | MOTS | Grant (A) | +8,334 | $0 | EDGAR |
| 2021-01-13 | CHRS | Grant (A) | — | $0 | EDGAR |
| 2020-10-13 | MOTS | Grant (A) | +9,430 | $0 | EDGAR |
| 2020-07-13 | MOTS | Grant (A) | +7,200 | $0 | EDGAR |
| 2020-02-07 | MOTS | Grant (A) | +12,500 | $0 | EDGAR |
| 2020-01-14 | CHRS | Grant (A) | — | $0 | EDGAR |
| 2019-02-15 | MOTS | Grant (A) | — | $0 | EDGAR |
| 2019-01-30 | CHRS | Grant (A) | — | $0 | EDGAR |